Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Blackrock Neurotech makes brain implants and electrode arrays that let researchers and paralyzed patients connect the brain to computers.
Blackrock Neurotech builds the hardware that lets the human brain talk to a machine. Its core products are tiny electrode arrays β small grids of needles that are implanted into the brain to pick up electrical signals from neurons β along with the connectors, cables, and processing systems that carry those signals out to a computer.
Researchers are the main customers. Neuroscience labs and university hospitals buy these arrays and systems to study how the brain works and to run clinical experiments. The most striking use: a paralyzed person thinks about moving a cursor or a robotic arm, and the implant reads those thoughts and turns them into commands. That's called a brain-computer interface, or BCI. The company, formerly called Blackrock Microsystems, sits in a rare spot. It sells the physical sensors and the software that reads them to both research labs and patient trials, rather than betting on one app. That makes it a picks-and-shovels supplier to a young field where many groups β academic, medical, and increasingly well-funded startups β are trying to turn brain signals into real-world control.
The business is small and research-driven today, and the hard part is turning lab hardware into something reliable enough for everyday patients. Brain implants must survive years inside the body, pass strict regulators, and win over doctors and insurers. That's a slow, expensive road, but if BCIs become a real medical treatment, the company already selling the arrays and systems into trials is standing near the front of the line.
Saved answer Β· last researched 16 Nov 2026